Twelve-month outcomes after SMILE Xtra in myopic eyes with borderline corneal parameters: a patient-level retrospective analysis

Background Small-incision lenticule extraction combined with accelerated corneal collagen cross-linking (SMILE Xtra) is used in selected myopic eyes with borderline corneal parameters. This study describes visual and refractive outcomes, keratometric changes, and recorded adverse events at 12 months. Methods This retrospective observational study included 19 patients (38 eyes). The primary postoperative assessment was at 12 months. Decimal visual acuity was converted to logMAR for each eye before right- and left-eye values were averaged for patient-level comparisons. Eye-level categorical outcomes were reported descriptively. All eyes underwent SMILE followed by intrastromal 0.22% riboflavin application and accelerated UV-A irradiation (30 mW/cm² for 90 s; 2.7 J/cm²). Results Mean age was 32.1 ± 5.9 years. Patient-level spherical equivalent improved from − 3.91 ± 1.90 D to − 0.50 ± 0.60 D ( p < 0.001). Mean uncorrected distance visual acuity improved from 0.523 ± 0.304 to 0.034 ± 0.053 logMAR ( p < 0.001). Corrected distance visual acuity was 0.020 ± 0.043 before surgery and 0.018 ± 0.038 logMAR at 12 months ( p = 0.331); no eye had a recorded decrease. Safety and efficacy indices were 1.00 and 0.97, respectively. Residual spherical equivalent was within ± 0.50 D of emmetropia in 20/38 eyes (52.6%) and within ± 1.00 D in 33/38 eyes (86.8%). Among 15 patients with paired keratometry, mean keratometry decreased from 43.91 ± 1.91 D to 41.48 ± 2.01 D ( p < 0.001). No clinically significant haze or clinically diagnosed ectasia was reported. Conclusions In this small selected cohort, SMILE Xtra was associated with improved uncorrected acuity and reduced myopic refractive error at 12 months, without recorded corrected-acuity loss. The study describes outcomes at a defined postoperative assessment; it does not establish longitudinal refractive or tomographic stability, an incremental benefit of cross-linking, or prevention of ectasia.

Authors

Institutions

Publication Details

Journal
BMC Ophthalmology
Published
2026-11-18
DOI
https://doi.org/10.1186/s12886-026-05553-7
Primary Topic
Corneal surgery and disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Twelve-month outcomes after SMILE Xtra in myopic eyes with borderline corneal parameters: a patient-level retrospective analysis

Serhat İmamoğlu, Mehmet KAY, Ercüment Bozkurt, Emirhan Ozkul
BMC Ophthalmology
Corneal surgery and disorders
article

Twelve-month outcomes after SMILE Xtra in myopic eyes with borderline corneal parameters: a patient-level retrospective analysis

Serhat İmamoğlu, Mehmet KAY, Ercüment Bozkurt, Emirhan Ozkul
article en

Abstract

Background Small-incision lenticule extraction combined with accelerated corneal collagen cross-linking (SMILE Xtra) is used in selected myopic eyes with borderline corneal parameters. This study describes visual and refractive outcomes, keratometric changes, and recorded adverse events at 12 months. Methods This retrospective observational study included 19 patients (38 eyes). The primary postoperative assessment was at 12 months. Decimal visual acuity was converted to logMAR for each eye before right- and left-eye values were averaged for patient-level comparisons. Eye-level categorical outcomes were reported descriptively. All eyes underwent SMILE followed by intrastromal 0.22% riboflavin application and accelerated UV-A irradiation (30 mW/cm² for 90 s; 2.7 J/cm²). Results Mean age was 32.1 ± 5.9 years. Patient-level spherical equivalent improved from − 3.91 ± 1.90 D to − 0.50 ± 0.60 D ( p < 0.001). Mean uncorrected distance visual acuity improved from 0.523 ± 0.304 to 0.034 ± 0.053 logMAR ( p < 0.001). Corrected distance visual acuity was 0.020 ± 0.043 before surgery and 0.018 ± 0.038 logMAR at 12 months ( p = 0.331); no eye had a recorded decrease. Safety and efficacy indices were 1.00 and 0.97, respectively. Residual spherical equivalent was within ± 0.50 D of emmetropia in 20/38 eyes (52.6%) and within ± 1.00 D in 33/38 eyes (86.8%). Among 15 patients with paired keratometry, mean keratometry decreased from 43.91 ± 1.91 D to 41.48 ± 2.01 D ( p < 0.001). No clinically significant haze or clinically diagnosed ectasia was reported. Conclusions In this small selected cohort, SMILE Xtra was associated with improved uncorrected acuity and reduced myopic refractive error at 12 months, without recorded corrected-acuity loss. The study describes outcomes at a defined postoperative assessment; it does not establish longitudinal refractive or tomographic stability, an incremental benefit of cross-linking, or prevention of ectasia.

BMC Ophthalmology
Üsküdar University (TR), Bahçeşehir University (TR), Istanbul Yeni Yüzyıl University (TR), Sağlık Bilimleri Üniversitesi (TR), Sancaktepe Şehit Prof. Dr. İlhan Varank Eğitim ve Araştırma Hastanesi (TR)
Good health and well-being
Corneal surgery and disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon